Pharma news
Pharma
From the Unified Patent Court to life sciences industrial strategy, there are many issues for Sean Dennehey to contend with as deputy CEO of the UK Intellectual Property Office. He talks to LSIPR about how he managed. 10 November 2017
Americas
Kyle Bass was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017
Americas
Tim Haines was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017
Americas
Debra Liebert was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the investment section, as LSIPR reports. 10 November 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s ruling that two Sanofi-owned patents are not invalid as obvious. 10 November 2017
Americas
Robert Nelsen was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017
Americas
Bryan Roberts was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 10 November 2017
Asia
Gyanendra Nath Singh and Krishnaswamy VijayRaghavan were selected in the LSIPR 50 2017 publication for their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports. 10 November 2017
Americas
Jane Philpott was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports. 10 November 2017
Africa
Matshidiso Moeti was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports. 10 November 2017